6505-99-131-5813
Rituximab Infusion
6505991315813 991315813 MABTHERA 10069169 EU/1/98/067/001 10073539 MABTHERA 100 MG L01X C02 08020300 03001052
INC: 77777
Managed by United Kingdom
NSN Created on 20 Jan 2003
Data Last Changed
January 2023
January 2023
NATO Update Count
1
1
NATO Data Quality
Marketplace 6505-99-131-5813
Need Help?
Request a Quotation from participating marketplace vendors
Request a Quotation from participating marketplace vendors
Related Documents 6505-99-131-5813 5+ Documents (More...)
MABTHERA 10069169 EU/1/98/067/001 10073539 MABTHERA 100 MG L01X C02 08020300 03001052 Managed by United
6505-99-131-5813 5+ Documents ( More... ) https//www.nsnlookup.com /fsg-65/fsc-6505/uk 6505-99-131-5813
Restrictions 6505-99-131-5813 DEMIL: | DEMILI : | CRITICALITY : | HMIC : | PMIC : | EDC: | ADPEC : 6505
6505-99-131-5813 5+ Documents ( More... ) https//www.nsnlookup.com /fsg-65/fsc-6505/uk 6505-99-131-5813
Restrictions 6505-99-131-5813 DEMIL: | DEMILI : | CRITICALITY : | HMIC : | PMIC : | EDC: | ADPEC : 6505
enable JavaScript in your web browser . 6505-99-549-5506Rituximab Infusion6505995495506 995495506 MABTHERA
10069170 EU/1/98/067/002 MABTHERA 500 MG 10073575 L01X C02 08020300 03001051 Managed by United Kingdom
Rituximab Infusion 6505991315813 991315813 enable JavaScript in your web browser . 6505-99-131-
10069170 EU/1/98/067/002 MABTHERA 500 MG 10073575 L01X C02 08020300 03001051 Managed by United Kingdom
Rituximab Infusion 6505991315813 991315813 enable JavaScript in your web browser . 6505-99-131-
enable JavaScript in your web browser . 6505-19-002-5322Rituximabe Solucao6505190025322 190025322 MABTHERA
www.nsnlookup.com /fsg-65/fsc-6505/es 6505-33-200-0375 Rituximab Inyectabl 6505332000375 332000375 MABTHERA
Rituximab Infusion 6505991315813 991315813 5322Rituximabe Solucao6505190025322 190025322 https/
www.nsnlookup.com /fsg-65/fsc-6505/es 6505-33-200-0375 Rituximab Inyectabl 6505332000375 332000375 MABTHERA
Rituximab Infusion 6505991315813 991315813 5322Rituximabe Solucao6505190025322 190025322 https/
enable JavaScript in your web browser . 6505-27-034-8696Rituksimab Flakon6505270348696 270348696 MABTHERA
Rituximab Infusion 6505991315813 991315813 enable JavaScript in your web browser . 6505-99-131-
enable JavaScript in your web browser . 6505-27-034-8696Rituksimab Flakon6505270348696 270348696 MABTHERA
Rituximab Infusion 6505991315813 991315813 enable JavaScript in your web browser . 6505-99-131-
enable JavaScript in your web browser . 6505-27-034-8696Rituksimab Flakon6505270348696 270348696 MABTHERA
enable JavaScript in your web browser . 6505-27-034-8700Rituksimab Flakon6505270348700 270348700 MABTHERA
Rituximab Infusion 6505991315813 991315813 Rituximab Inyectabl 6505332000375 332000375 MABTHERA
enable JavaScript in your web browser . 6505-27-034-8700Rituksimab Flakon6505270348700 270348700 MABTHERA
Rituximab Infusion 6505991315813 991315813 Rituximab Inyectabl 6505332000375 332000375 MABTHERA
enable JavaScript in your web browser . 6505-27-034-8700Rituksimab Flakon6505270348700 270348700 MABTHERA
Restrictions 6505-99-131-5813
End Users 6505-99-131-5813
- Australia (ZA)
- United Kingdom (ZK)
Approved Sources 6505-99-131-5813
- Part Number
- Manufacturer
- Status
- MABTHERA
- Manufacturer
- U6024 - Roche Products Ltd (Active)
- Incomplete Reference
- Incomplete Reference
- 10069169
- SCE69 - F. Hoffmann-La Roche Ltd (Active)
- Secondary Buy
- Secondary Buy
- EU/1/98/067/001
- U6024 - Roche Products Ltd (Active)
- Secondary Buy
- Secondary Buy
- 10073539
- Z0811 - Roche Products Pty Ltd (Active)
- Secondary Buy
- Secondary Buy
- MABTHERA 100 MG
- U6024 - Roche Products Ltd (Active)
- Secondary Buy
- Secondary Buy
- L01X C02
- I9022 - Who Collaborating Centre For Drug (Active)
- NATO Reference
- NATO Reference
- 08020300
- KB332 - British Medical Association (Active)
- NATO Reference
- NATO Reference
- 03001052
- U9124 - Ministry Of Defence, Code Reserved (Active)
- NATO Reference
- NATO Reference
Similar Supply Items to 6505-99-131-5813
